Immunometabolic Pathways: Investigating Mediators of Major Depressive Disorder and Atherosclerotic Cardiovascular Disease Comorbidity
These analyses identified biomarkers shared in MDD and CVDs and may drive comorbid pathology risk.
Authors
- Jos A. Bosch (ORCID: https://orcid.org/0000-0001-7780-4806)
- Dimitrios I. Fotiadis (ORCID: https://orcid.org/0000-0002-7362-5082)
- Arja O. Rydin (ORCID: https://orcid.org/0000-0002-5525-3350)
- Costas Papaloukas (ORCID: https://orcid.org/0000-0002-6736-5536)
- Rick Quax (ORCID: https://orcid.org/0000-0002-0299-0074)
- Femke Lamers (ORCID: https://orcid.org/0000-0003-4344-5766)
- Antonis I. Sakellarios (ORCID: https://orcid.org/0000-0002-2272-9543)
- Kevin Dobretz (ORCID: https://orcid.org/0000-0001-9138-4836)
- Angela Koloi (ORCID: https://orcid.org/0009-0001-8197-3749)
- Nabila P R Siregar
Institutions
- University of Geneva (CH)
- University of Patras (GR)
- University of Ioannina (GR)
- University Hospital of Geneva (CH)
- GGD Amsterdam (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
- Foundation for Research and Technology Hellas (GR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Biological Psychiatry Global Open Science
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1016/j.bpsgos.2025.100528
- Citations
- 3
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.73
Funders
- European Commission
- Universiteit Leiden
- Leids Universitair Medisch Centrum
- Universitair Medisch Centrum Groningen